NCT00530530View on ClinicalTrials.gov

ASP8825 - Study in Patients With Restless Legs Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

474

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Restless Legs Syndrome
Interventions
DRUG

ASP8825

oral

DRUG

Placebo

oral

Trial Locations (6)

Unknown

Chugoku

Hokkaido

Kansai

Kanto

Kyusyu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00530530 - ASP8825 - Study in Patients With Restless Legs Syndrome | Biotech Hunter | Biotech Hunter